ES2172520T3 - Medicamento para el tratamiento de la septicemia y del choque septico. - Google Patents

Medicamento para el tratamiento de la septicemia y del choque septico.

Info

Publication number
ES2172520T3
ES2172520T3 ES94107265T ES94107265T ES2172520T3 ES 2172520 T3 ES2172520 T3 ES 2172520T3 ES 94107265 T ES94107265 T ES 94107265T ES 94107265 T ES94107265 T ES 94107265T ES 2172520 T3 ES2172520 T3 ES 2172520T3
Authority
ES
Spain
Prior art keywords
treatment
septic shock
medicinal product
septicemia
components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94107265T
Other languages
English (en)
Inventor
Gerhard Dr Dickneite
Klaus Dr Bosslet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Behring GmbH Deutschland
Original Assignee
Aventis Behring GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Behring GmbH filed Critical Aventis Behring GmbH
Application granted granted Critical
Publication of ES2172520T3 publication Critical patent/ES2172520T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

LA INVENCION SE REFIERE A UN SISTEMA DE DOS COMPONENTES PARA EL TRATAMIENTO Y PROFILAXIS DE LA SEPSIA Y SE SHOCK SEPTICO, DONDE LOS COMPONENTES ESTAN DETERMINADOS, EN COMBINACION UNO CON OTRO PARA SU ACCION EN UN MEDICAMENTO, ASI COMO UNA UNIDAD DE EMPAQUETADO CONTENIENDO AMBOS COMPONENTES. SE DESCRIBE TAMBIEN UN PROCESO PARA SU ELABORACION.
ES94107265T 1993-05-25 1994-05-10 Medicamento para el tratamiento de la septicemia y del choque septico. Expired - Lifetime ES2172520T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4317282A DE4317282A1 (de) 1993-05-25 1993-05-25 Arzneimittel zur Behandlung der Sepsis und des septischen Schocks

Publications (1)

Publication Number Publication Date
ES2172520T3 true ES2172520T3 (es) 2002-10-01

Family

ID=6488808

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94107265T Expired - Lifetime ES2172520T3 (es) 1993-05-25 1994-05-10 Medicamento para el tratamiento de la septicemia y del choque septico.

Country Status (9)

Country Link
US (1) US20040214756A1 (es)
EP (1) EP0629406B1 (es)
JP (1) JP3739816B2 (es)
KR (1) KR100352196B1 (es)
AT (1) ATE213641T1 (es)
AU (1) AU688309B2 (es)
CA (1) CA2124161C (es)
DE (2) DE4317282A1 (es)
ES (1) ES2172520T3 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1027894A3 (en) * 1999-01-28 2001-01-24 Aventis Behring Gesellschaft mit beschränkter Haftung Pharmaceutical preparation for the treatment of inflammatory processes
EP1023902A1 (en) 1999-01-28 2000-08-02 Aventis Behring Gesellschaft mit beschränkter Haftung Pharmaceutical preparation for the treatment of inflammatory processes
DE19937656A1 (de) * 1999-08-13 2001-02-15 Aventis Behring Gmbh Verwendung von Antithrombin III zur Prophylaxe und Therapie von Erkrankungen
WO2014033551A2 (en) * 2012-08-31 2014-03-06 Medizinische Universitaet Innsbruck The use of direct thrombin inhibitors in critically ill patients

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994367A (en) * 1988-10-07 1991-02-19 East Carolina University Extended shelf life platelet preparations and process for preparing the same
DE4115453A1 (de) * 1991-05-11 1992-11-12 Knoll Ag Neue wirkstoffkombination

Also Published As

Publication number Publication date
CA2124161A1 (en) 1994-11-26
JP3739816B2 (ja) 2006-01-25
ATE213641T1 (de) 2002-03-15
US20040214756A1 (en) 2004-10-28
DE59410056D1 (de) 2002-04-04
DE4317282A1 (de) 1994-12-01
JPH06336440A (ja) 1994-12-06
KR100352196B1 (ko) 2003-09-06
EP0629406A1 (de) 1994-12-21
EP0629406B1 (de) 2002-02-27
AU688309B2 (en) 1998-03-12
CA2124161C (en) 2008-11-18
AU6326194A (en) 1994-12-01

Similar Documents

Publication Publication Date Title
ES2098140T3 (es) Liosferas que contienen gonadotropina.
IT8123700A0 (it) L'applicazione in terapeutica dei derivati del 4,5,6,7-tetraidroisossozolo(5,4-c)piridin-3-olo come miotonolitici.
ES2125535T5 (es) Mezclas, que contienen isocianatos emulsionables en agua.
ES2086623T3 (es) Azaheterociclilmetil-cromanos como principios activos para el tratamiento de enfermedades del sistema nervioso central.
ES2174895T3 (es) Combinaciones metalicas complejas con contenido en carbenos heterociclicos.
ES2141931T3 (es) Procedimiento de fraccionamiento de una solucion.
CO4440626A1 (es) Amidas terapeuticas
ES2146741T3 (es) Derivados de rapamicina utiles como inmunosupresores.
ES2120447T3 (es) Procedimiento para preparar resinas a base de epihalohidrina que tienen un contenido reducido de halogeno.
ES2154262T3 (es) Uso de compuestos macrolidos para enfermedades oculares.
ES2068202T3 (es) Composicion liquida suavizante para prendas de ropa.
ES428915A1 (es) Un procedimiento para la preparacion de aminobenzo (b,d) piranos.
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
ES2187850T3 (es) Procedimiento para la evaluacion del potencial de material de musgo esfacno para la absorcion de liquidos.
ATA935578A (de) Aufreissbare verschlusskapsel, insbesondere flaschenkapsel
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
PE103799A1 (es) Procedimiento de purificacion de mesilato de alatrofloxacino
IL64292A0 (en) D-homosteroids,their manufacture and pharmaceutical compositions containing them
ES2097887T3 (es) Polimero de carboxivinilo con viscosidad newtoniana.
ES2161762T3 (es) Polimeros de ionenos como antihelminticos en animales.
ES2170798T3 (es) Benzopiranos y su uso como agentes terapeuticos.
DE60006558D1 (de) Stabile lösung von calcitriol zum verpacken in phiolen
ES2172520T3 (es) Medicamento para el tratamiento de la septicemia y del choque septico.
ES2180729T3 (es) Tratamiento terapeutico combinado de las patologias hiperproliferantes.
ES2034285T3 (es) Procedimiento de obtencion de principios tanicos de origen vegetal, composicion cosmetologica y composicion farmaceutica que contienen el principio tanico purificado obtenido segun el procedimiento.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 629406

Country of ref document: ES